Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| 1 |
CVS Health
CVS
|
+$604M |
| 2 |
Occidental Petroleum
OXY
|
+$566M |
| 3 |
3M
MMM
|
+$474M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 5 |
Kraft Heinz
KHC
|
+$391M |
Top Sells
| 1 |
Sempra
SRE
|
+$699M |
| 2 |
Merck
MRK
|
+$533M |
| 3 |
Cummins
CMI
|
+$489M |
| 4 |
UBS Group
UBS
|
+$467M |
| 5 |
Apple
AAPL
|
+$464M |
Sector Composition
| 1 | Healthcare | 16.18% |
| 2 | Technology | 15.88% |
| 3 | Financials | 14.31% |
| 4 | Industrials | 9.16% |
| 5 | Communication Services | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
General Mills
GIS
$26.7B
| $20.2M | 0.01% |
384,160
-121,853
| -24% | -$6.4M |
|
702
Bio-Rad Laboratories Class A
BIO
$7.49B
| $20.2M | 0.01% |
64,528
+12,800
| +25% | +$4M |
|
703
Gran Tierra Energy
GTE
$143M
| $20.1M | 0.01% |
1,283,982
-38,151
| -3% | -$598K |
|
704
Alexandria Real Estate Equities
ARE
$14.3B
| $20.1M | 0.01% |
142,505
-15,355
| -10% | -$2.17M |
|
705
Evercore
EVR
$12.8B
| $20.1M | 0.01% |
226,459
+2,660
| +1% | +$236K |
|
706
Acadia Pharmaceuticals
ACAD
$4.02B
| $20M | 0.01% |
749,790
| – | – |
|
707
CRISPR Therapeutics
CRSP
$4.71B
| $20M | 0.01% |
424,613
| – | – |
|
708
Healthpeak Properties
DOC
$12.5B
| $19.9M | 0.01% |
622,447
-11,205
| -2% | -$358K |
|
709
Brookfield Infrastructure Partners
BIP
$14.2B
| $19.9M | 0.01% |
778,152
-102,480
| -12% | -$2.61M |
|
710
Novo Nordisk
NVO
$242B
| $19.3M | 0.01% |
756,826
-72,084
| -9% | -$1.84M |
|
711
New Oriental
EDU
$9.04B
| $19.3M | 0.01% |
199,350
+186,322
| +1,430% | +$18M |
|
712
Marsh & McLennan
MMC
$97.7B
| $19.1M | 0.01% |
191,386
+40,261
| +27% | +$4.02M |
|
713
Ares Management
ARES
$39.3B
| $18.9M | 0.01% |
+724,000
| New | +$18.9M |
|
714
Las Vegas Sands
LVS
$37.4B
| $18.9M | 0.01% |
320,325
-40,482
| -11% | -$2.39M |
|
715
Neogen
NEOG
$1.21B
| $18.9M | 0.01% |
609,356
-58
| -0% | -$1.8K |
|
|
BLUE
716
DELISTED
bluebird bio
BLUE
| $18.9M | 0.01% |
11,480
| – | – |
|
717
Emergent Biosolutions
EBS
$425M
| $18.8M | 0.01% |
389,534
+182,197
| +88% | +$8.8M |
|
718
Xencor
XNCR
$596M
| $18.7M | 0.01% |
457,432
| – | – |
|
|
DFS
719
DELISTED
Discover Financial Services
DFS
| $18.7M | 0.01% |
240,612
+74,475
| +45% | +$5.78M |
|
720
Simpson Manufacturing
SSD
$7.97B
| $18.5M | 0.01% |
278,638
-55,979
| -17% | -$3.72M |
|
|
BPY
721
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $18.4M | 0.01% |
971,752
-25,073
| -3% | -$474K |
|
|
GSS
722
DELISTED
Golden Star Resources Ltd.
GSS
| $18.3M | 0.01% |
4,538,333
-85,000
| -2% | -$343K |
|
723
Incyte
INCY
$16.8B
| $18.3M | 0.01% |
215,134
-20,347
| -9% | -$1.73M |
|
724
Phillips 66
PSX
$53.1B
| $18.2M | 0.01% |
194,749
+39,499
| +25% | +$3.69M |
|
725
Dick's Sporting Goods
DKS
$18.2B
| $18.1M | 0.01% |
523,963
+18,938
| +4% | +$656K |
|